doug peddicord the director of the association also defends the industry's track record. >> concerns the clinical research enterprise is amazingly safe and amazingly productive. >> peddicord says there's stootoo much at stake for the industry to tolerate unethical treatment. >> in the instances we've seen bad actors, we've often seize those bad actors go out of business rather promptly. >> we took our findings to u.s. senator chuck grassley. he faults the agency for not exercising enough authority. >> fda is in the position of policing the entire operation. they are the 900-pound gorilla. they need to act like a 900-pound gorilla. >> grassley believes the fda needs to get involved early in the planning and supervising of clinical trials, not just review drug company test results after they're done. >> he they don't oversee those clinical trials until most them are completed. then they see the results. to what extent can they trust the results? >> the fda responded in a statement that it is already strongly engaged in the clinical research process from inspecting drug makers and their